Compare VCYT & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCYT | ACLS |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2013 | 2000 |
| Metric | VCYT | ACLS |
|---|---|---|
| Price | $32.67 | $104.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $44.33 | ★ $101.50 |
| AVG Volume (30 Days) | ★ 776.9K | 599.6K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | 0.82 | ★ 3.80 |
| Revenue | N/A | ★ $839,048,000.00 |
| Revenue This Year | $13.48 | $1.93 |
| Revenue Next Year | $12.67 | $7.91 |
| P/E Ratio | $39.16 | ★ $25.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.61 | $43.00 |
| 52 Week High | $50.71 | $102.93 |
| Indicator | VCYT | ACLS |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 67.19 |
| Support Level | $31.22 | $78.24 |
| Resistance Level | $33.95 | N/A |
| Average True Range (ATR) | 1.43 | 5.41 |
| MACD | 0.23 | 1.04 |
| Stochastic Oscillator | 68.36 | 99.20 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.